MOHAN PANKAJ (Chairman, President and CEO) received a stock award from SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/17/2023ACC: 0001493152-23-005473
DirectorOfficer· Chairman, President and CEO
Since Apr 2020
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
73.56K acquired · 73.56K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−73.56K
Price / share
—
Trade value
—
% of position
60.4%
1/7/2023
121.73K→48.17K
Common Stock
Direct
Shares
+73.56K
Price / share
—
Trade value
—
% of position
152.7%
1/7/2023
48.17K→121.73K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/7/2023 | D · Disposition | −73.56K | — | — | 60.4% | 121.73K | 48.17K |
| Common Stock Direct | 1/7/2023 | A · Award | +73.56K | — | — | 152.7% | 48.17K | 121.73K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned66.48K
Common Stock
IndirectShares owned570.00
Total
67.05K indirect67.05K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 66.48K | Indirect |
| Common Stock | 570.00 | Indirect |
| Total | 67.05K | 67.05K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported